The reduction of 18:1- and 16:1-containing PS species (36:1, 36:2, 38:5, 38:4, 38:3, 40:4) by LIPE inhibition is interesting given that these species have been identified as increased in the cerebral cortex of PD patients78. This evidence concerns the gene LIPE and Parkinson disease.